Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 12 entries
Sorted by: Best Match Show Resources per page
Development of a simple droplet-based microfluidic capillary viscometer for low-viscosity Newtonian fluids.

Analytical chemistry

DeLaMarre MF, Keyzer A, Shippy SA.
PMID: 25825941
Anal Chem. 2015 May 05;87(9):4649-57. doi: 10.1021/acs.analchem.5b00677. Epub 2015 Apr 15.

Viscosity is an easily measured macroscopic property that provides molecular information and is widely used across the sciences and engineering. Here we report a microfluidic capillary viscometer that forms droplets from aqueous samples in an immiscible carrier phase and...

Cite
DeLaMarre MF, Keyzer A, Shippy SA. Development of a simple droplet-based microfluidic capillary viscometer for low-viscosity Newtonian fluids. Anal Chem. 2015;87(9):4649-57doi: 10.1021/acs.analchem.5b00677.
DeLaMarre, M. F., Keyzer, A., & Shippy, S. A. (2015). Development of a simple droplet-based microfluidic capillary viscometer for low-viscosity Newtonian fluids. Analytical chemistry, 87(9), 4649-57. https://doi.org/10.1021/acs.analchem.5b00677
DeLaMarre, Michael F, et al. "Development of a simple droplet-based microfluidic capillary viscometer for low-viscosity Newtonian fluids." Analytical chemistry vol. 87,9 (2015): 4649-57. doi: https://doi.org/10.1021/acs.analchem.5b00677
DeLaMarre MF, Keyzer A, Shippy SA. Development of a simple droplet-based microfluidic capillary viscometer for low-viscosity Newtonian fluids. Anal Chem. 2015 May 05;87(9):4649-57. doi: 10.1021/acs.analchem.5b00677. Epub 2015 Apr 15. PMID: 25825941.
Copy Download .nbib Format: NLM
Advances in Chronic Rhinosinusitis 2020/2021.

The Journal of allergy and clinical immunology

Xu Z, Huang Y, Delemarre T, Cavaliere C, Zhang N, Bachert C.
PMID: 34973298
J Allergy Clin Immunol. 2021 Dec 29; doi: 10.1016/j.jaci.2021.12.782. Epub 2021 Dec 29.

Major progress has been achieved in the understanding and clinical practice of chronic rhinosinusitis, with or without nasal polyps. These advances resulted in a better understanding of the pathophysiology, the distribution into subgroups and consequently in a better management...

Cite
Xu Z, Huang Y, Delemarre T, et al. Advances in Chronic Rhinosinusitis 2020/2021. J Allergy Clin Immunol. 2021;doi: 10.1016/j.jaci.2021.12.782.
Xu, Z., Huang, Y., Delemarre, T., Cavaliere, C., Zhang, N., & Bachert, C. (2021). Advances in Chronic Rhinosinusitis 2020/2021. The Journal of allergy and clinical immunology, . https://doi.org/10.1016/j.jaci.2021.12.782
Xu, Zhaofeng, et al. "Advances in Chronic Rhinosinusitis 2020/2021." The Journal of allergy and clinical immunology vol. (2021). doi: https://doi.org/10.1016/j.jaci.2021.12.782
Xu Z, Huang Y, Delemarre T, Cavaliere C, Zhang N, Bachert C. Advances in Chronic Rhinosinusitis 2020/2021. J Allergy Clin Immunol. 2021 Dec 29; doi: 10.1016/j.jaci.2021.12.782. Epub 2021 Dec 29. PMID: 34973298.
Copy Download .nbib Format: NLM
Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitution.

Oncotarget

Kellner JN, Delemarre EM, Yvon E, Nierkens S, Boelens JJ, McNiece I, Olson A, Nieto Y, Ciurea S, Popat U, Ahmed S, Champlin R, Ramos J, Nishimoto M, Ma H, Ke Z, Thall P, Khoury JD, Negrin R, Andersson B, Parmar S.
PMID: 30479692
Oncotarget. 2018 Nov 02;9(86):35611-35622. doi: 10.18632/oncotarget.26242. eCollection 2018 Nov 02.

Incubation of umbilical cord blood (UCB) derived regulatory T-cells (Tregs) with fucosyltransferase enzyme improves their ability to home to the target tissue to prevent graft vs. host disease (GVHD). We report results of 5 patients (Double UCB Transplant, n=2;...

Cite
Kellner JN, Delemarre EM, Yvon E, et al. Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitution. Oncotarget. 2018;9(86):35611-35622doi: 10.18632/oncotarget.26242.
Kellner, J. N., Delemarre, E. M., Yvon, E., Nierkens, S., Boelens, J. J., McNiece, I., Olson, A., Nieto, Y., Ciurea, S., Popat, U., Ahmed, S., Champlin, R., Ramos, J., Nishimoto, M., Ma, H., Ke, Z., Thall, P., Khoury, J. D., Negrin, R., Andersson, B., & Parmar, S. (2018). Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitution. Oncotarget, 9(86), 35611-35622. https://doi.org/10.18632/oncotarget.26242
Kellner, Joshua N, et al. "Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitution." Oncotarget vol. 9,86 (2018): 35611-35622. doi: https://doi.org/10.18632/oncotarget.26242
Kellner JN, Delemarre EM, Yvon E, Nierkens S, Boelens JJ, McNiece I, Olson A, Nieto Y, Ciurea S, Popat U, Ahmed S, Champlin R, Ramos J, Nishimoto M, Ma H, Ke Z, Thall P, Khoury JD, Negrin R, Andersson B, Parmar S. Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitution. Oncotarget. 2018 Nov 02;9(86):35611-35622. doi: 10.18632/oncotarget.26242. eCollection 2018 Nov 02. PMID: 30479692; PMCID: PMC6235025.
Copy Download .nbib Format: NLM
Development of a simplified microfluidic injector for analysis of droplet content via capillary electrophoresis.

Analytical chemistry

DeLaMarre MF, Shippy SA.
PMID: 25226066
Anal Chem. 2014 Oct 21;86(20):10193-200. doi: 10.1021/ac502272q. Epub 2014 Oct 01.

Droplet-based microfluidic platforms sequester nanoliter to picoliter samples in an immiscible carrier phase and have gained notoriety for their ability to be used in laboratory procedures on a miniaturized scale. Recently, droplet microfluidics has been used to prevent zone...

Cite
DeLaMarre MF, Shippy SA. Development of a simplified microfluidic injector for analysis of droplet content via capillary electrophoresis. Anal Chem. 2014;86(20):10193-200doi: 10.1021/ac502272q.
DeLaMarre, M. F., & Shippy, S. A. (2014). Development of a simplified microfluidic injector for analysis of droplet content via capillary electrophoresis. Analytical chemistry, 86(20), 10193-200. https://doi.org/10.1021/ac502272q
DeLaMarre, Michael F, and Shippy, Scott A. "Development of a simplified microfluidic injector for analysis of droplet content via capillary electrophoresis." Analytical chemistry vol. 86,20 (2014): 10193-200. doi: https://doi.org/10.1021/ac502272q
DeLaMarre MF, Shippy SA. Development of a simplified microfluidic injector for analysis of droplet content via capillary electrophoresis. Anal Chem. 2014 Oct 21;86(20):10193-200. doi: 10.1021/ac502272q. Epub 2014 Oct 01. PMID: 25226066.
Copy Download .nbib Format: NLM
Unravelling the expression of interleukin-9 in chronic rhinosinusitis: A possible role for Staphylococcus aureus.

Clinical and translational allergy

Delemarre T, De Ruyck N, Holtappels G, Bachert C, Gevaert E.
PMID: 33292477
Clin Transl Allergy. 2020 Oct 29;10(1):41. doi: 10.1186/s13601-020-00348-5.

Chronic rhinosinusitis with nasal polyps (CRSwNP) is a Th2 biased inflammation, associated with nasal colonization of Staphylococcus (S.) aureus. Interleukin (IL)-9 is a pro-inflammatory Th2 cytokine with a pivotal role in asthma, allergy and chronic obstructive pulmonary disease (COPD),...

Cite
Delemarre T, De Ruyck N, Holtappels G, et al. Unravelling the expression of interleukin-9 in chronic rhinosinusitis: A possible role for Staphylococcus aureus. Clin Transl Allergy. 2020;10(1):41doi: 10.1186/s13601-020-00348-5.
Delemarre, T., De Ruyck, N., Holtappels, G., Bachert, C., & Gevaert, E. (2020). Unravelling the expression of interleukin-9 in chronic rhinosinusitis: A possible role for Staphylococcus aureus. Clinical and translational allergy, 10(1), 41. https://doi.org/10.1186/s13601-020-00348-5
Delemarre, Tim, et al. "Unravelling the expression of interleukin-9 in chronic rhinosinusitis: A possible role for Staphylococcus aureus." Clinical and translational allergy vol. 10,1 (2020): 41. doi: https://doi.org/10.1186/s13601-020-00348-5
Delemarre T, De Ruyck N, Holtappels G, Bachert C, Gevaert E. Unravelling the expression of interleukin-9 in chronic rhinosinusitis: A possible role for Staphylococcus aureus. Clin Transl Allergy. 2020 Oct 29;10(1):41. doi: 10.1186/s13601-020-00348-5. PMID: 33292477; PMCID: PMC7597062.
Copy Download .nbib Format: NLM
Serum Biomarker Profile Including CCL1, CXCL10, VEGF, and Adenosine Deaminase Activity Distinguishes Active From Remotely Acquired Latent Tuberculosis.

Frontiers in immunology

Delemarre EM, van Hoorn L, Bossink AWJ, Drylewicz J, Joosten SA, Ottenhoff THM, Akkerman OW, Goletti D, Petruccioli E, Navarra A, van den Broek BTA, Paardekooper SPA, van Haeften I, Koenderman L, Lammers JJ, Thijsen SFT, Hofland RW, Nierkens S.
PMID: 34691031
Front Immunol. 2021 Oct 07;12:725447. doi: 10.3389/fimmu.2021.725447. eCollection 2021.

INTRODUCTION: There is an urgent medical need to differentiate active tuberculosis (ATB) from latent tuberculosis infection (LTBI) and prevent undertreatment and overtreatment. The aim of this study was to identify biomarker profiles that may support the differentiation between ATB...

Cite
Delemarre EM, van Hoorn L, Bossink AWJ, et al. Serum Biomarker Profile Including CCL1, CXCL10, VEGF, and Adenosine Deaminase Activity Distinguishes Active From Remotely Acquired Latent Tuberculosis. Front Immunol. 2021;12:725447doi: 10.3389/fimmu.2021.725447.
Delemarre, E. M., van Hoorn, L., Bossink, A. W. J., Drylewicz, J., Joosten, S. A., Ottenhoff, T. H. M., Akkerman, O. W., Goletti, D., Petruccioli, E., Navarra, A., van den Broek, B. T. A., Paardekooper, S. P. A., van Haeften, I., Koenderman, L., Lammers, J. J., Thijsen, S. F. T., Hofland, R. W., & Nierkens, S. (2021). Serum Biomarker Profile Including CCL1, CXCL10, VEGF, and Adenosine Deaminase Activity Distinguishes Active From Remotely Acquired Latent Tuberculosis. Frontiers in immunology, 12725447. https://doi.org/10.3389/fimmu.2021.725447
Delemarre, Eveline M, et al. "Serum Biomarker Profile Including CCL1, CXCL10, VEGF, and Adenosine Deaminase Activity Distinguishes Active From Remotely Acquired Latent Tuberculosis." Frontiers in immunology vol. 12 (2021): 725447. doi: https://doi.org/10.3389/fimmu.2021.725447
Delemarre EM, van Hoorn L, Bossink AWJ, Drylewicz J, Joosten SA, Ottenhoff THM, Akkerman OW, Goletti D, Petruccioli E, Navarra A, van den Broek BTA, Paardekooper SPA, van Haeften I, Koenderman L, Lammers JJ, Thijsen SFT, Hofland RW, Nierkens S. Serum Biomarker Profile Including CCL1, CXCL10, VEGF, and Adenosine Deaminase Activity Distinguishes Active From Remotely Acquired Latent Tuberculosis. Front Immunol. 2021 Oct 07;12:725447. doi: 10.3389/fimmu.2021.725447. eCollection 2021. PMID: 34691031; PMCID: PMC8529994.
Copy Download .nbib Format: NLM
From the waste paper basket: total AV block?.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Wijnmaalen AP, van den Berg TM, Delemarre BJ.
PMID: 25696642
Neth Heart J. 2006 Jun;14(6):232-238.

No abstract available.

Cite
Wijnmaalen AP, van den Berg TM, Delemarre BJ. From the waste paper basket: total AV block?. Neth Heart J. 2006;14(6):232-238
Wijnmaalen, A. P., van den Berg, T. M., & Delemarre, B. J. (2006). From the waste paper basket: total AV block?. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 14(6), 232-238.
Wijnmaalen, A P, et al. "From the waste paper basket: total AV block?." Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation vol. 14,6 (2006): 232-238.
Wijnmaalen AP, van den Berg TM, Delemarre BJ. From the waste paper basket: total AV block?. Neth Heart J. 2006 Jun;14(6):232-238. PMID: 25696642; PMCID: PMC2557247.
Copy Download .nbib Format: NLM
Immune Monitoring during Therapy Reveals Activitory and Regulatory Immune Responses in High-Risk Neuroblastoma.

Cancers

Szanto CL, Cornel AM, Tamminga SM, Delemarre EM, de Koning CCH, van den Beemt DAMH, Dunnebach E, Tas ML, Dierselhuis MP, Tytgat LGAM, van Noesel MM, Kraal KCJM, Boelens JJ, Huitema ADR, Nierkens S, Geismar H.
PMID: 33926057
Cancers (Basel). 2021 Apr 26;13(9). doi: 10.3390/cancers13092096.

Despite intensive treatment, including consolidation immunotherapy (IT), prognosis of high-risk neuroblastoma (HR-NBL) is poor. Immune status of patients over the course of treatment, and thus immunological features potentially explaining therapy efficacy, are largely unknown. In this study, the dynamics...

Cite
Szanto CL, Cornel AM, Tamminga SM, et al. Immune Monitoring during Therapy Reveals Activitory and Regulatory Immune Responses in High-Risk Neuroblastoma. Cancers (Basel). 2021;13(9)doi: 10.3390/cancers13092096.
Szanto, C. L., Cornel, A. M., Tamminga, S. M., Delemarre, E. M., de Koning, C. C. H., van den Beemt, D. A. M. H., Dunnebach, E., Tas, M. L., Dierselhuis, M. P., Tytgat, L. G. A. M., van Noesel, M. M., Kraal, K. C. J. M., Boelens, J. J., Huitema, A. D. R., Nierkens, S., & Geismar, H. (2021). Immune Monitoring during Therapy Reveals Activitory and Regulatory Immune Responses in High-Risk Neuroblastoma. Cancers, 13(9), . https://doi.org/10.3390/cancers13092096
Szanto, Celina L, et al. "Immune Monitoring during Therapy Reveals Activitory and Regulatory Immune Responses in High-Risk Neuroblastoma." Cancers vol. 13,9 (2021). doi: https://doi.org/10.3390/cancers13092096
Szanto CL, Cornel AM, Tamminga SM, Delemarre EM, de Koning CCH, van den Beemt DAMH, Dunnebach E, Tas ML, Dierselhuis MP, Tytgat LGAM, van Noesel MM, Kraal KCJM, Boelens JJ, Huitema ADR, Nierkens S, Geismar H. Immune Monitoring during Therapy Reveals Activitory and Regulatory Immune Responses in High-Risk Neuroblastoma. Cancers (Basel). 2021 Apr 26;13(9). doi: 10.3390/cancers13092096. PMID: 33926057; PMCID: PMC8123570.
Copy Download .nbib Format: NLM
The haemodynamic cascade.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Delemarre BJ.
PMID: 24150598
Neth Heart J. 2013 Nov;21(11):485-6. doi: 10.1007/s12471-013-0476-x.

No abstract available.

Cite
Delemarre BJ. The haemodynamic cascade. Neth Heart J. 2013;21(11):485-6doi: 10.1007/s12471-013-0476-x.
Delemarre, B. J. (2013). The haemodynamic cascade. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 21(11), 485-6. https://doi.org/10.1007/s12471-013-0476-x
Delemarre, B J M. "The haemodynamic cascade." Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation vol. 21,11 (2013): 485-6. doi: https://doi.org/10.1007/s12471-013-0476-x
Delemarre BJ. The haemodynamic cascade. Neth Heart J. 2013 Nov;21(11):485-6. doi: 10.1007/s12471-013-0476-x. PMID: 24150598; PMCID: PMC3824744.
Copy Download .nbib Format: NLM
Unraveling heterogeneity in pediatric atopic dermatitis: Identification of serum biomarker based patient clusters.

The Journal of allergy and clinical immunology

Bakker DS, de Graaf M, Nierkens S, Delemarre EM, Knol E, van Wijk F, de Bruin-Weller MS, Drylewicz J, Thijs JL.
PMID: 34237306
J Allergy Clin Immunol. 2021 Jul 06; doi: 10.1016/j.jaci.2021.06.029. Epub 2021 Jul 06.

BACKGROUND: Increasing evidence shows that pediatric atopic dermatitis (AD) differs from adult AD on a biologic level. Broad biomarker profiling across a wide range of ages of pediatric patients with AD is lacking.OBJECTIVE: Our aim was to identify serum...

Cite
Bakker DS, de Graaf M, Nierkens S, et al. Unraveling heterogeneity in pediatric atopic dermatitis: Identification of serum biomarker based patient clusters. J Allergy Clin Immunol. 2021;doi: 10.1016/j.jaci.2021.06.029.
Bakker, D. S., de Graaf, M., Nierkens, S., Delemarre, E. M., Knol, E., van Wijk, F., de Bruin-Weller, M. S., Drylewicz, J., & Thijs, J. L. (2021). Unraveling heterogeneity in pediatric atopic dermatitis: Identification of serum biomarker based patient clusters. The Journal of allergy and clinical immunology, . https://doi.org/10.1016/j.jaci.2021.06.029
Bakker, Daphne S, et al. "Unraveling heterogeneity in pediatric atopic dermatitis: Identification of serum biomarker based patient clusters." The Journal of allergy and clinical immunology vol. (2021). doi: https://doi.org/10.1016/j.jaci.2021.06.029
Bakker DS, de Graaf M, Nierkens S, Delemarre EM, Knol E, van Wijk F, de Bruin-Weller MS, Drylewicz J, Thijs JL. Unraveling heterogeneity in pediatric atopic dermatitis: Identification of serum biomarker based patient clusters. J Allergy Clin Immunol. 2021 Jul 06; doi: 10.1016/j.jaci.2021.06.029. Epub 2021 Jul 06. PMID: 34237306.
Copy Download .nbib Format: NLM
Novel imaging strategies for the detection of prosthetic heart valve obstruction and endocarditis.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Tanis W, Budde RP, van der Bilt IA, Delemarre B, Hoohenkerk G, van Rooden JK, Scholtens AM, Habets J, Chamuleau S.
PMID: 26744343
Neth Heart J. 2016 Feb;24(2):96-107. doi: 10.1007/s12471-015-0796-0.

Prosthetic heart valve (PHV) dysfunction remains difficult to recognise correctly by two-dimensional (2D) transthoracic and transoesophageal echocardiography (TTE/TEE). ECG-triggered multidetector-row computed tomography (MDCT), 18-fluorine-fluorodesoxyglucose positron emission tomography including low-dose CT (FDG-PET) and three-dimensional transoesophageal echocardiography (3D-TEE) may have additional...

Cite
Tanis W, Budde RP, van der Bilt IA, et al. Novel imaging strategies for the detection of prosthetic heart valve obstruction and endocarditis. Neth Heart J. 2016;24(2):96-107doi: 10.1007/s12471-015-0796-0.
Tanis, W., Budde, R. P., van der Bilt, I. A., Delemarre, B., Hoohenkerk, G., van Rooden, J. K., Scholtens, A. M., Habets, J., & Chamuleau, S. (2016). Novel imaging strategies for the detection of prosthetic heart valve obstruction and endocarditis. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 24(2), 96-107. https://doi.org/10.1007/s12471-015-0796-0
Tanis, W, et al. "Novel imaging strategies for the detection of prosthetic heart valve obstruction and endocarditis." Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation vol. 24,2 (2016): 96-107. doi: https://doi.org/10.1007/s12471-015-0796-0
Tanis W, Budde RP, van der Bilt IA, Delemarre B, Hoohenkerk G, van Rooden JK, Scholtens AM, Habets J, Chamuleau S. Novel imaging strategies for the detection of prosthetic heart valve obstruction and endocarditis. Neth Heart J. 2016 Feb;24(2):96-107. doi: 10.1007/s12471-015-0796-0. PMID: 26744343; PMCID: PMC4722008.
Copy Download .nbib Format: NLM
Unraveling heterogeneity in pediatric atopic dermatitis: Identification of serum biomarker based patient clusters.

The Journal of allergy and clinical immunology

Bakker DS, de Graaf M, Nierkens S, Delemarre EM, Knol E, van Wijk F, de Bruin-Weller MS, Drylewicz J, Thijs JL.
PMID: 34237306
J Allergy Clin Immunol. 2022 Jan;149(1):125-134. doi: 10.1016/j.jaci.2021.06.029. Epub 2021 Jul 06.

BACKGROUND: Increasing evidence shows that pediatric atopic dermatitis (AD) differs from adult AD on a biologic level. Broad biomarker profiling across a wide range of ages of pediatric patients with AD is lacking.OBJECTIVE: Our aim was to identify serum...

Cite
Bakker DS, de Graaf M, Nierkens S, et al. Unraveling heterogeneity in pediatric atopic dermatitis: Identification of serum biomarker based patient clusters. J Allergy Clin Immunol. 2021;149(1):125-134doi: 10.1016/j.jaci.2021.06.029.
Bakker, D. S., de Graaf, M., Nierkens, S., Delemarre, E. M., Knol, E., van Wijk, F., de Bruin-Weller, M. S., Drylewicz, J., & Thijs, J. L. (2022). Unraveling heterogeneity in pediatric atopic dermatitis: Identification of serum biomarker based patient clusters. The Journal of allergy and clinical immunology, 149(1), 125-134. https://doi.org/10.1016/j.jaci.2021.06.029
Bakker, Daphne S, et al. "Unraveling heterogeneity in pediatric atopic dermatitis: Identification of serum biomarker based patient clusters." The Journal of allergy and clinical immunology vol. 149,1 (2022): 125-134. doi: https://doi.org/10.1016/j.jaci.2021.06.029
Bakker DS, de Graaf M, Nierkens S, Delemarre EM, Knol E, van Wijk F, de Bruin-Weller MS, Drylewicz J, Thijs JL. Unraveling heterogeneity in pediatric atopic dermatitis: Identification of serum biomarker based patient clusters. J Allergy Clin Immunol. 2022 Jan;149(1):125-134. doi: 10.1016/j.jaci.2021.06.029. Epub 2021 Jul 06. PMID: 34237306.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 12 entries